Management of tuberculosis during pregnancy and puerperium

We reported 22 cases with tuberculosis in pregnancy and puerperium, who were treated in our hospital from 1993 to 2001. Nine out of 22 cases were foreign women and the onset of tuberculosis was not clear and the diagnosis tended to be delayed in most cases. In the reports from industrial countries,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kekkaku 2002-11, Vol.77 (11), p.703
Hauptverfasser: Toyota, Emiko, Minoura, Shigeki, Miyazawa, Hirofumi
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page 703
container_title Kekkaku
container_volume 77
creator Toyota, Emiko
Minoura, Shigeki
Miyazawa, Hirofumi
description We reported 22 cases with tuberculosis in pregnancy and puerperium, who were treated in our hospital from 1993 to 2001. Nine out of 22 cases were foreign women and the onset of tuberculosis was not clear and the diagnosis tended to be delayed in most cases. In the reports from industrial countries, most of those patients are foreign bone and the delay in diagnosis is common because symptoms are apt to be mixed up those for pregnancy and puerperium. In 10 of 22 cases, extrapulmonary lesions were noted. Most of our cases were treated with INH, RFP and EB, and in some severer cases PZA was added. WHO and BTS recommend standard therapy with PZA but ATS recommends INH, RFP and EB without PZA. Generally SM is contraindicated because of adverse effect of hearing loss for all pregnant periods, and the data for PZA and other second line drugs are insufficient. Our cases and their neonates showed normal course and no malformation nor congenital tuberculosis. 2 cases could not keep adherence for drugs and 2 babies got active tuberculosis. Precaution for infection is one of most important problem to deal with cases with tuberculosis during pregnancy and postpartum in the hospital. If she is still infectious on delivery, we should consider prevention for transmission and manage her in isolated manner. CDC recommends not to treat for latent tuberculosis during pregnancy because of high frequency of hepatic damage due to INH. It is the best way to check and treat latent tuberculosis before gestation if she is at high risk with tuberculosis.
doi_str_mv 10.11400/kekkaku1923.77.703
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_12494507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12494507</sourcerecordid><originalsourceid>FETCH-LOGICAL-j245t-fdfa695570c36f516f7ee19f93db3f711daacd7b51432b7a3615719500d70cd33</originalsourceid><addsrcrecordid>eNo1j0tOwzAUAL0A0ar0BEjIF0h5z588zA5VQJGK2MC6smM7CmncyIkXvT1IwGpWM9IwdoOwQVQAd33oe9sXNEJuiDYE8oItAYSoDFG9YOtp6hwAGAXyXl2xBQpllAZasoc3m2wbhpBmfop8Li7kphxPUzdxX3KXWj7m0CabmjO3yfOxhDyG3JXhml1Ge5zC-o8r9vn89LHdVfv3l9ft4776EkrPVfTR1kZrgkbWUWMdKQQ00UjvZCREb23jyWlUUjiyskZNaDSA_1G8lCt2-9sdixuCP4y5G2w-H_4n5DeEF0pW</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Management of tuberculosis during pregnancy and puerperium</title><source>J-STAGE Free</source><source>MEDLINE</source><creator>Toyota, Emiko ; Minoura, Shigeki ; Miyazawa, Hirofumi</creator><creatorcontrib>Toyota, Emiko ; Minoura, Shigeki ; Miyazawa, Hirofumi</creatorcontrib><description>We reported 22 cases with tuberculosis in pregnancy and puerperium, who were treated in our hospital from 1993 to 2001. Nine out of 22 cases were foreign women and the onset of tuberculosis was not clear and the diagnosis tended to be delayed in most cases. In the reports from industrial countries, most of those patients are foreign bone and the delay in diagnosis is common because symptoms are apt to be mixed up those for pregnancy and puerperium. In 10 of 22 cases, extrapulmonary lesions were noted. Most of our cases were treated with INH, RFP and EB, and in some severer cases PZA was added. WHO and BTS recommend standard therapy with PZA but ATS recommends INH, RFP and EB without PZA. Generally SM is contraindicated because of adverse effect of hearing loss for all pregnant periods, and the data for PZA and other second line drugs are insufficient. Our cases and their neonates showed normal course and no malformation nor congenital tuberculosis. 2 cases could not keep adherence for drugs and 2 babies got active tuberculosis. Precaution for infection is one of most important problem to deal with cases with tuberculosis during pregnancy and postpartum in the hospital. If she is still infectious on delivery, we should consider prevention for transmission and manage her in isolated manner. CDC recommends not to treat for latent tuberculosis during pregnancy because of high frequency of hepatic damage due to INH. It is the best way to check and treat latent tuberculosis before gestation if she is at high risk with tuberculosis.</description><identifier>ISSN: 0022-9776</identifier><identifier>DOI: 10.11400/kekkaku1923.77.703</identifier><identifier>PMID: 12494507</identifier><language>jpn</language><publisher>Japan</publisher><subject>Adult ; Antitubercular Agents - administration &amp; dosage ; Antitubercular Agents - adverse effects ; Contraindications ; Drug Therapy, Combination ; Female ; Humans ; Infant, Newborn ; Japan ; Practice Guidelines as Topic ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Puerperal Infection - drug therapy ; Retrospective Studies ; Tuberculosis - drug therapy ; Tuberculosis - prevention &amp; control ; Tuberculosis - transmission</subject><ispartof>Kekkaku, 2002-11, Vol.77 (11), p.703</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12494507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toyota, Emiko</creatorcontrib><creatorcontrib>Minoura, Shigeki</creatorcontrib><creatorcontrib>Miyazawa, Hirofumi</creatorcontrib><title>Management of tuberculosis during pregnancy and puerperium</title><title>Kekkaku</title><addtitle>Kekkaku</addtitle><description>We reported 22 cases with tuberculosis in pregnancy and puerperium, who were treated in our hospital from 1993 to 2001. Nine out of 22 cases were foreign women and the onset of tuberculosis was not clear and the diagnosis tended to be delayed in most cases. In the reports from industrial countries, most of those patients are foreign bone and the delay in diagnosis is common because symptoms are apt to be mixed up those for pregnancy and puerperium. In 10 of 22 cases, extrapulmonary lesions were noted. Most of our cases were treated with INH, RFP and EB, and in some severer cases PZA was added. WHO and BTS recommend standard therapy with PZA but ATS recommends INH, RFP and EB without PZA. Generally SM is contraindicated because of adverse effect of hearing loss for all pregnant periods, and the data for PZA and other second line drugs are insufficient. Our cases and their neonates showed normal course and no malformation nor congenital tuberculosis. 2 cases could not keep adherence for drugs and 2 babies got active tuberculosis. Precaution for infection is one of most important problem to deal with cases with tuberculosis during pregnancy and postpartum in the hospital. If she is still infectious on delivery, we should consider prevention for transmission and manage her in isolated manner. CDC recommends not to treat for latent tuberculosis during pregnancy because of high frequency of hepatic damage due to INH. It is the best way to check and treat latent tuberculosis before gestation if she is at high risk with tuberculosis.</description><subject>Adult</subject><subject>Antitubercular Agents - administration &amp; dosage</subject><subject>Antitubercular Agents - adverse effects</subject><subject>Contraindications</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Japan</subject><subject>Practice Guidelines as Topic</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Puerperal Infection - drug therapy</subject><subject>Retrospective Studies</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - prevention &amp; control</subject><subject>Tuberculosis - transmission</subject><issn>0022-9776</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tOwzAUAL0A0ar0BEjIF0h5z588zA5VQJGK2MC6smM7CmncyIkXvT1IwGpWM9IwdoOwQVQAd33oe9sXNEJuiDYE8oItAYSoDFG9YOtp6hwAGAXyXl2xBQpllAZasoc3m2wbhpBmfop8Li7kphxPUzdxX3KXWj7m0CabmjO3yfOxhDyG3JXhml1Ge5zC-o8r9vn89LHdVfv3l9ft4776EkrPVfTR1kZrgkbWUWMdKQQ00UjvZCREb23jyWlUUjiyskZNaDSA_1G8lCt2-9sdixuCP4y5G2w-H_4n5DeEF0pW</recordid><startdate>20021101</startdate><enddate>20021101</enddate><creator>Toyota, Emiko</creator><creator>Minoura, Shigeki</creator><creator>Miyazawa, Hirofumi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20021101</creationdate><title>Management of tuberculosis during pregnancy and puerperium</title><author>Toyota, Emiko ; Minoura, Shigeki ; Miyazawa, Hirofumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j245t-fdfa695570c36f516f7ee19f93db3f711daacd7b51432b7a3615719500d70cd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Antitubercular Agents - administration &amp; dosage</topic><topic>Antitubercular Agents - adverse effects</topic><topic>Contraindications</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Japan</topic><topic>Practice Guidelines as Topic</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Puerperal Infection - drug therapy</topic><topic>Retrospective Studies</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - prevention &amp; control</topic><topic>Tuberculosis - transmission</topic><toplevel>online_resources</toplevel><creatorcontrib>Toyota, Emiko</creatorcontrib><creatorcontrib>Minoura, Shigeki</creatorcontrib><creatorcontrib>Miyazawa, Hirofumi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Kekkaku</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toyota, Emiko</au><au>Minoura, Shigeki</au><au>Miyazawa, Hirofumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of tuberculosis during pregnancy and puerperium</atitle><jtitle>Kekkaku</jtitle><addtitle>Kekkaku</addtitle><date>2002-11-01</date><risdate>2002</risdate><volume>77</volume><issue>11</issue><spage>703</spage><pages>703-</pages><issn>0022-9776</issn><abstract>We reported 22 cases with tuberculosis in pregnancy and puerperium, who were treated in our hospital from 1993 to 2001. Nine out of 22 cases were foreign women and the onset of tuberculosis was not clear and the diagnosis tended to be delayed in most cases. In the reports from industrial countries, most of those patients are foreign bone and the delay in diagnosis is common because symptoms are apt to be mixed up those for pregnancy and puerperium. In 10 of 22 cases, extrapulmonary lesions were noted. Most of our cases were treated with INH, RFP and EB, and in some severer cases PZA was added. WHO and BTS recommend standard therapy with PZA but ATS recommends INH, RFP and EB without PZA. Generally SM is contraindicated because of adverse effect of hearing loss for all pregnant periods, and the data for PZA and other second line drugs are insufficient. Our cases and their neonates showed normal course and no malformation nor congenital tuberculosis. 2 cases could not keep adherence for drugs and 2 babies got active tuberculosis. Precaution for infection is one of most important problem to deal with cases with tuberculosis during pregnancy and postpartum in the hospital. If she is still infectious on delivery, we should consider prevention for transmission and manage her in isolated manner. CDC recommends not to treat for latent tuberculosis during pregnancy because of high frequency of hepatic damage due to INH. It is the best way to check and treat latent tuberculosis before gestation if she is at high risk with tuberculosis.</abstract><cop>Japan</cop><pmid>12494507</pmid><doi>10.11400/kekkaku1923.77.703</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-9776
ispartof Kekkaku, 2002-11, Vol.77 (11), p.703
issn 0022-9776
language jpn
recordid cdi_pubmed_primary_12494507
source J-STAGE Free; MEDLINE
subjects Adult
Antitubercular Agents - administration & dosage
Antitubercular Agents - adverse effects
Contraindications
Drug Therapy, Combination
Female
Humans
Infant, Newborn
Japan
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Infectious - drug therapy
Puerperal Infection - drug therapy
Retrospective Studies
Tuberculosis - drug therapy
Tuberculosis - prevention & control
Tuberculosis - transmission
title Management of tuberculosis during pregnancy and puerperium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T09%3A10%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20tuberculosis%20during%20pregnancy%20and%20puerperium&rft.jtitle=Kekkaku&rft.au=Toyota,%20Emiko&rft.date=2002-11-01&rft.volume=77&rft.issue=11&rft.spage=703&rft.pages=703-&rft.issn=0022-9776&rft_id=info:doi/10.11400/kekkaku1923.77.703&rft_dat=%3Cpubmed%3E12494507%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12494507&rfr_iscdi=true